Non-Invasive Hormone Therapies and Alternative Interventions for Menopausal Symptom Management: A Systematic Review

This systematic review explores non-invasive hormone therapies and alternative interventions for managing menopausal and perimenopausal symptoms. Utilizing the Synthory.AI service for automated synthesis, 51 studies from 2018 to 2025 were analyzed. Key findings include the efficacy of non-hormonal neurokinin receptor antagonists, such as Fezolinetant, in reducing vasomotor symptoms and improving quality of life. Comparative analyses highlight the variability in outcomes across non-invasive therapies, underscoring the need for standardized protocols. Regional disparities in prescribing practices and concerns over risks like hypertension with hormonal therapies were also noted. Future research should focus on diverse cohorts and longer-term outcomes to optimize treatment strategies for menopausal women.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-28
DOI
https://doi.org/10.5281/zenodo.15299409
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Non-Invasive Hormone Therapies and Alternative Interventions for Menopausal Symptom Management: A Systematic Review

Zenodo (CERN European Organization for Nuclear Research)
Menopause: Health Impacts and Treatments
article

Non-Invasive Hormone Therapies and Alternative Interventions for Menopausal Symptom Management: A Systematic Review

article en

Abstract

This systematic review explores non-invasive hormone therapies and alternative interventions for managing menopausal and perimenopausal symptoms. Utilizing the Synthory.AI service for automated synthesis, 51 studies from 2018 to 2025 were analyzed. Key findings include the efficacy of non-hormonal neurokinin receptor antagonists, such as Fezolinetant, in reducing vasomotor symptoms and improving quality of life. Comparative analyses highlight the variability in outcomes across non-invasive therapies, underscoring the need for standardized protocols. Regional disparities in prescribing practices and concerns over risks like hypertension with hormonal therapies were also noted. Future research should focus on diverse cohorts and longer-term outcomes to optimize treatment strategies for menopausal women.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 42%
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.